Aspira Women’s Health (NASDAQ:AWH – Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.21) per share and revenue of $3.00 million for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
Aspira Women’s Health Trading Up 0.8 %
Shares of NASDAQ:AWH opened at $0.12 on Thursday. The stock has a market capitalization of $2.09 million, a PE ratio of -0.10 and a beta of 1.57. Aspira Women’s Health has a 1 year low of $0.11 and a 1 year high of $3.81. The firm has a fifty day moving average price of $0.32 and a 200 day moving average price of $0.64.
Wall Street Analyst Weigh In
Separately, StockNews.com started coverage on shares of Aspira Women’s Health in a report on Sunday, January 12th. They issued a “hold” rating for the company.
About Aspira Women’s Health
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Featured Articles
- Five stocks we like better than Aspira Women’s Health
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Investing in the High PE Growth Stocks
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Stock Splits, Do They Really Impact Investors?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.
